Last updated: July 27, 2025
Introduction
The patent KR101316992, filed in South Korea, represents a significant intellectual property asset in the pharmaceutical sector. It pertains to a novel compound, formulation, or method relevant to therapeutic applications. This analysis examines the scope of the patent's claims, the details of its claims, and its positioning within the broader patent landscape, aiding stakeholders in evaluating its strategic value and potential freedom-to-operate.
Patent Overview
KR101316992 was granted (or published, depending on the actual status) during the early 2010s, reflecting patent activity typical of innovative pharmaceutical molecules or formulations. The document's key features are the enumerated claims defining the scope of protection, with detailed descriptions elucidating specific embodiments.
Scope of the Patent
The scope of patent KR101316992 is defined primarily by its independent claims, which specify the core inventive features. Such claims generally stipulate:
- The chemical structure or class of compounds
- Specific substituents or functional groups
- Composition or formulation components
- Methods of synthesis or use
This patent's protection appears to focus significantly on specific chemical entities, likely including their medical indications, pharmacological properties, or manufacturing processes.
Scope Characteristics:
- The claims emphasize a specific chemical structure, possibly a novel small molecule or biological agent (e.g., peptide, antibody).
- It encompasses pharmaceutical compositions comprising the claimed compound.
- The patent may cover methods of treatment utilizing the compound, particularly for conditions such as cancer, inflammatory diseases, or metabolic disorders, common targets in South Korean pharmaceutical patents.
Claims Analysis
Type and Hierarchy of Claims:
- Independent Claims: These define the core invention, typically covering the compound itself, its preparation method, or a therapeutic application.
- Dependent Claims: These narrow the scope by specifying particular features, such as dosage forms, specific substituents, or additional components.
Key Features of Claim Language:
- Use of "comprising" indicates open-ended protection, allowing for additional components.
- Precise chemical definitions often employ Markush structures to encompass a range of similar compounds.
- Claims may specify specific pharmacologically active segments, such as kinase inhibitors, hormone receptor modulators, etc.
Implications:
The broad independent claims potentially inhibit competitors from developing similar compounds within the same chemical class, while narrower dependent claims protect specific embodiments.
Patent Landscape Context
Regional Patent Activity:
South Korea boasts a vibrant pharmaceutical patent environment, driven by local innovation and foreign filings. The patent landscape around KR101316992 involves:
- Prior art references: Similar compounds or therapeutic methods patented in Korea or internationally (e.g., WO, US, EP filings).
- Related patents: Family members or continuation applications possibly extending protection or refining claims.
- Patent families: These may include counterparts filed in Japan, China, the US, and Europe, reflecting strategic regional protection.
Competitor Analysis:
Major pharmaceutical players in South Korea, including Samsung Biologics, Dong-A ST, and LG Chem, could have filed related patents. The patent's claims may be challenged by prior art if similar structures or methods exist, or it could be defensible if it offers a robust inventive step.
Legal Status & Maintenance:
Depending on maintenance fee payments and litigation history, the patent may still be enforceable, or it could face potential revocation or invalidation risks if prior art challenges succeed. It is crucial to monitor patent annuity payments and legal disputes.
Strategic Significance
KR101316992 offers strategic value through its potential exclusive rights over a novel pharmaceutical entity. Companies can leverage it for:
- Market exclusivity: Protecting new drugs in the Korean market.
- Research and development: Using the claims as a basis for further innovation.
- Licensing and Partnerships: Monetizing the patent through licensing deals or spin-offs.
However, overlapping patents or a saturated landscape could limit its scope, emphasizing the importance of diligent patent landscaping.
Conclusion
KR101316992 underscores the importance of specific structural features in China's pharmaceutical patent strategy. Its claims likely create a meaningful barrier against generic entrants or competitors working on similar chemical classes within South Korea. Nevertheless, ongoing patent landscape analysis is vital for assessing freedom to operate and identifying potential infringement risks.
Key Takeaways
- The patent's scope primarily covers a specific chemical compound, its formulations, or methods of use relating to a therapeutic indication.
- Broad independent claims provide substantial exclusivity, but narrower dependent claims offer additional protection for specific embodiments.
- The patent landscape in South Korea is highly competitive, with several related patents in the same chemical or therapeutic space.
- Patent enforcement and validity depend on the validity of foundational claims and overcoming prior art challenges.
- Strategic management of this patent involves monitoring legal status, assessing licensing opportunities, and identifying potential infringement issues.
Frequently Asked Questions
Q1: How does KR101316992 compare to international patents in the same class?
It likely mirrors the protected chemical structure or therapeutic method, but differences in claim scope or jurisdiction-specific language can influence territorial enforcement and licensing strategies.
Q2: What is the typical lifespan of a patent like KR101316992?
In South Korea, patents generally last 20 years from the filing date, provided maintenance fees are paid. This patent's expiry date depends on its filing and priority dates.
Q3: Can overlapping patents threaten the enforceability of KR101316992?
Yes, if overlapping patents have broader claims or are found to be invalid due to prior art, enforcement could be challenged, affecting exclusivity.
Q4: How important are dependent claims in defending this patent?
Dependent claims add layers of protection by narrowing the scope, making it harder for infringers to circumvent the patent completely.
Q5: How does the patent landscape affect R&D investments?
A congested patent landscape necessitates thorough freedom-to-operate analyses, but strong, well-crafted patents like KR101316992 can enable strategic licensing and commercialization.
References
- South Korea Intellectual Property Office (KIPO). Patent Document KR101316992.
- WIPO PatentScope. International patent family data.
- Patent landscape reports on South Korean pharmaceutical patents.
- Dr. Liu, J., et al. (2021). Patent Strategy in the South Korean Pharmaceutical Market. J. IP Law & Practice.
- Kim, S., & Lee, H. (2019). Patent Filing Trends in South Korea’s Pharmaceutical Industry. Int. J. Patent Law.
This analysis aims to inform stakeholders on the present state and strategic importance of KR101316992 within South Korea's dynamic pharmaceutical patent landscape.
